Cancer Biology

Michael Savona, MD, has received a competitive grant to develop therapies for patients with myelodysplastic syndromes. Read More

Vanderbilt’s six newest endowed chairs were honored by colleagues, university leaders, family members and donors at a ceremony on April 30 in the Student Life Center. Read More

The Howard Hughes Medical Institute has awarded 2018 Gilliam Fellowships for Advanced Study—created to ensure that a diverse and highly trained workforce is prepared to assume leadership roles in the sciences—to three Vanderbilt University doctoral students and their advisers. Read More

Vanderbilt investigators have discovered that cancer treatment induces an “idling” state for cells, which could promote resistance to treatment. Read More

To develop strategies for preventing radiation-induced lung fibrosis (scarring), Vanderbilt investigators are exploring the cell types and factors that contribute to the fibrotic response. Read More

A compound identified at Vanderbilt represents a new lead for treating rare, aggressive childhood cancers called Ewing sarcomas. Read More

A research symposium honoring the career of Harold (Hal) Moses, M.D., who founded and served as director emeritus of Vanderbilt-Ingram Cancer Center, has been slated for Wednesday, Oct. 11, 7:45 a.m. – 3:30 p.m., at the Vanderbilt Student Life Center. Read More

A research symposium honoring the career of Dr. Hal Moses, Hortense B. Ingram Chair in Cancer Research and professor of cancer biology, is planned for Oct. 11 at the Student Life Center. RSVP to attend the symposium through Oct. 2. Read More

New findings could explain the link between chronic stress and reduced survival in women diagnosed with breast cancer, and could lead to new strategies to improve treatment outcomes. Read More

Using bioinformatics approaches, Vanderbilt investigators have identified gene expression networks that are deregulated in mouse and human stomach cancers. Read More

Vanderbilt University engineers find existing human protein is ideal carrier for powerful molecules that can signal tumors to self-destruct. Read More

Signaling through a complex of proteins called mTORC2 plays a role in breast cancer migration, invasion and metastasis, Vanderbilt researchers reported. Read More

  Christine Lovly, Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology at Vanderbilt University Medical Center (VUMC), has been elected to The American Society for Clinical Investigation (ASCI). The ASCI is an elite honor society of physician-scientists. The Society, founded in 1908,… Read More

An inhibitor of cell metabolism may be a good therapeutic target for neuroblastoma, which accounts for about 15 percent of pediatric cancer-related deaths. Read More

New findings that reveal complex interactions in esophageal adenocarcinoma could lead to diagnostic, prognostic or therapeutic biomarkers. Read More

With the help of a drug formerly used to treat HIV/AIDS, researchers at Vanderbilt University Medical Center (VUMC) have found a way to make melanoma cells more vulnerable to targeted anti-cancer therapy. Read More

Vanderbilt researchers hope their new method to describe cells will be widely adopted and used to generate a “Who’s Who” database of cell types. Read More

A signaling protein overexpressed in upper gastrointestinal cancers is an attractive therapeutic target. Read More

"Diverse: Issues In Higher Education" has ranked Vanderbilt University No. 1 in the country for the number of doctoral degrees awarded to African Americans in the biological and biomedical sciences. Read More

A new method will make it possible to study solid tumors and healthy tissues using mass cytometry. Read More